Skip to content
Preprint · CC-BY via OpenAlex

Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments

Eric P. Jiang, Arjun Dinesh, Sohan Jadhav, Richard A. Miller, Gonzalo G. Garcia

Life Sciences · 2023 · ▲ 22 citations

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.lfs.2023.121904
Canonical
link ↗
Fetched
2026-06-13 MST

Cite this

APA
Jiang, E.P., Dinesh, A., Jadhav, S., Miller, R.A., &amp; Garcia, G.G. (2023). Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments. <em>Life Sciences</em>. https://doi.org/10.1016/j.lfs.2023.121904
Vancouver
Jiang EP, Dinesh A, Jadhav S, Miller RA, Garcia GG. Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments. Life Sciences. 2023. doi:10.1016/j.lfs.2023.121904.
BibTeX
@unpublished{eric2023Canagl, title = {Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments}, author = {Eric P. Jiang and Arjun Dinesh and Sohan Jadhav and Richard A. Miller and Gonzalo G. Garcia}, journal = {Life Sciences}, year = {2023}, doi = {10.1016/j.lfs.2023.121904}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings